OBJECTIVE: To investigate the capabilities of ultrahigh-resolution optical coherence tomography (UHR OCT); to compare with the commercially available OCT standard-resolution system, StratusOCT, for imaging of idiopathic juxtafoveal retinal telangiectasis (IJT); and to demonstrate that UHR OCT provides additional information on disease morphology, pathogenesis, and management. DESIGN: Retrospective, observational, interventional case series. PARTICIPANTS: Nineteen eyes of 10 patients diagnosed with IJT in at least one eye. METHOD: All patients were imaged with UHR OCT and StratusOCT at the same visit. A subset of patients was also imaged before and after treatment of IJT. MAIN OUTCOME MEASURES: Ultrahigh- and standard-resolution cross-sectional tomograms of IJT pathology. RESULTS: Using both standard- and ultrahigh-resolution OCT, we identified the following features of IJT: (1) a lack of correlation between retinal thickening on OCT and leakage on fluorescein angiography, (2) loss and disruption of the photoreceptor layer, (3) cystlike structures in the foveola and within internal retinal layers such as the inner nuclear or ganglion cell layers, (4) a unique internal limiting membrane draping across the foveola related to an underlying loss of tissue, (5) intraretinal neovascularization near the fovea, and (6) central intraretinal deposits and plaques. In 63% of cases, the presence of abnormal vessels and a discontinuity of the photoreceptor layer correlated with visual acuity. CONCLUSIONS: Ultrahigh-resolution OCT improves visualization of the retinal pathology associated with IJT and allows identification of new features associated with it. Some of these features, such as discontinuity of the photoreceptor layer, are revealed only by UHR OCT.
OBJECTIVE: To investigate the capabilities of ultrahigh-resolution optical coherence tomography (UHR OCT); to compare with the commercially available OCT standard-resolution system, StratusOCT, for imaging of idiopathic juxtafoveal retinal telangiectasis (IJT); and to demonstrate that UHR OCT provides additional information on disease morphology, pathogenesis, and management. DESIGN: Retrospective, observational, interventional case series. PARTICIPANTS: Nineteen eyes of 10 patients diagnosed with IJT in at least one eye. METHOD: All patients were imaged with UHR OCT and StratusOCT at the same visit. A subset of patients was also imaged before and after treatment of IJT. MAIN OUTCOME MEASURES: Ultrahigh- and standard-resolution cross-sectional tomograms of IJT pathology. RESULTS: Using both standard- and ultrahigh-resolution OCT, we identified the following features of IJT: (1) a lack of correlation between retinal thickening on OCT and leakage on fluorescein angiography, (2) loss and disruption of the photoreceptor layer, (3) cystlike structures in the foveola and within internal retinal layers such as the inner nuclear or ganglion cell layers, (4) a unique internal limiting membrane draping across the foveola related to an underlying loss of tissue, (5) intraretinal neovascularization near the fovea, and (6) central intraretinal deposits and plaques. In 63% of cases, the presence of abnormal vessels and a discontinuity of the photoreceptor layer correlated with visual acuity. CONCLUSIONS: Ultrahigh-resolution OCT improves visualization of the retinal pathology associated with IJT and allows identification of new features associated with it. Some of these features, such as discontinuity of the photoreceptor layer, are revealed only by UHR OCT.
Authors: P Massin; C Allouch; B Haouchine; F Metge; M Paques; L Tangui; A Erginay; A Gaudric Journal: Am J Ophthalmol Date: 2000-12 Impact factor: 5.258
Authors: Martin Gloesmann; Boris Hermann; Christian Schubert; Harald Sattmann; Peter K Ahnelt; Wolfgang Drexler Journal: Invest Ophthalmol Vis Sci Date: 2003-04 Impact factor: 4.799
Authors: Lelia A Paunescu; Joel S Schuman; Lori Lyn Price; Paul C Stark; Siobahn Beaton; Hiroshi Ishikawa; Gadi Wollstein; James G Fujimoto Journal: Invest Ophthalmol Vis Sci Date: 2004-06 Impact factor: 4.799
Authors: C A Toth; D G Narayan; S A Boppart; M R Hee; J G Fujimoto; R Birngruber; C P Cain; C D DiCarlo; W P Roach Journal: Arch Ophthalmol Date: 1997-11
Authors: Eric K Chin; Dae Yu Kim; Allan A Hunter; Suman Pilli; Machelle Wilson; Robert J Zawadzki; John S Werner; Susanna S Park Journal: Invest Ophthalmol Vis Sci Date: 2013-07-02 Impact factor: 4.799
Authors: Igor Kozak; Victoria L Morrison; Thomas M Clark; Dirk-Uwe Bartsch; Byung Ro Lee; Iryna Falkenstein; Ajay M Tammewar; Francesca Mojana; William R Freeman Journal: Retina Date: 2008-04 Impact factor: 4.256
Authors: Michael B Powner; Mark C Gillies; Marina Tretiach; Andrew Scott; Robyn H Guymer; Gregory S Hageman; Marcus Fruttiger Journal: Ophthalmology Date: 2010-08-03 Impact factor: 12.079
Authors: Ferenc B Sallo; Tunde Peto; Catherine Egan; Ute E K Wolf-Schnurrbusch; Traci E Clemons; Mark C Gillies; Daniel Pauleikhoff; Gary S Rubin; Emily Y Chew; Alan C Bird Journal: Invest Ophthalmol Vis Sci Date: 2012-11-29 Impact factor: 4.799